Description: Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
Home Page: www.sphchina.com
Shanghai Pharmaceutical Building
Shanghai,
200020
China
Phone:
86 21 6373 0908
Officers
| Name | Title |
|---|---|
| Mr. Man Cho | Pres & Exec. Director |
| Mr. Bo Shen | CFO, VP, Head of the Accounting Department & Exec. Director |
| Mr. Yongzhong Li | VP & Exec. Director |
| Dr. Shunjiang Yu | Chief Medical Officer |
| Ms. Shui Bing Leung A.C.S. | Joint Company Sec. |
| Mr. Tao Zhong | VP, Board Sec. & Joint Company Sec. |
| Jinqi Yu | Gen. Mang. |
| Ying Ke | Director & Gen. Mang. of R&D Management Center |
| Linqiong Dong | Securities Affairs Representative |
Exchange: HK
Country: HK
Currency: Hong Kong Dollar (HK$)
| Forward PE: | 8.3542 |
|---|---|
| Trailing PE: | 7.2984 |
| Price-to-Book MRQ: | 0.6876 |
| Price-to-Sales TTM: | 0.318 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 47056 |